Forlong Biotechology to Present Clinical Data from FL115, a novel interleukin-15 (IL-15) superagonist, in Late-breaking Session at 40th SITC Annual Meeting Forlong Biotechnology, a clinical-stage ...
Forlong Dosed First Patient in Phase 2 Clinical Trial of FL115, a novel interleukin-15 (IL-15) superagonist, for nonmuscle invasive bladder cancer (NMIBC) Forlong Biotechnology, a clinical-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback